Evogene Ltd.

Regulatory Filings • Apr 7, 2021

Evogene to Hold Virtual Investor & Analyst Days

Hebrew language event on Monday, April 19, 2021

English language event on Wednesday, April 21, 2021

Rehovot, Israel – April 7th, 2021 – Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.

The meetings will feature key-note presentations from Evogene's CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.

• The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link: https://zoom.us/webinar/register/WN\_MpdKOdKeTvqyR6LDbpJlCQ
• The English language event will be held on Wednesday, April 21, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link: https://zoom.us/webinar/register/WN\_k8B2V0g\_R9e1xYv5WIpt6A

Questions to the speakers may be sent in advance of the event via the registration link or to ir@evogene.com or may be sent via the Question and Answer link in the zoom webinar during the event.

About Evogene Ltd.:

Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.

Evogene Investor Contact: US Investor Relations:

Rivka Neufeld / Aviva Banczewski Investor Relations E: IR@evogene.com T: +972-8-931-1900

Joseph Green Edison Group E: jgreen@edisongroup.com T: +1 646-653-7030

Laine Yonker Edison Group E: lyonker@edisongroup.com T: +1 646-653-7035